Osteoblast and osteoclast modulation by triterpenes and ellagitannins from Bischofia javanica leaves
Planta Medica · 01.03.2026 · 92 (03) · 212-213
DOI: 10.1055/s-0045-1814898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von T Raviraj und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Bischofia javanica (‘茄冬 Jia Dong’, Phyllanthaceae family), is traditionally used in Taiwan to treat joint inflammation, asthma, and infections. It is also consumed as a culinary ingredient to promote musculoskeletal strength, as reflected in folkloric practices by renowned artist Hsu Po-Yih (許伯夷). Maintaining homeostasis requires balanced nutrition and immune regulation, both essential for muscle, organ, and nerve development, while imbalance contributes to chronic conditions like osteoporosis [ 1 ], diabetes, and cancer. Given its long-standing use and safety profile, B. javanica is a promising candidate for further biomedical investigation [ 2 ]. This study evaluated the effects of B. javanica extracts with different polarities on bone cell differentiation. The crude 80% ethanolic (10 μg/mL) and 80% methanolic (80 μg/mL) extracts significantly promoted osteoblast differentiation (induced ALP activity) and inhibited osteoclast formation (reduced TRAP activity). Notably, the hexane fraction (80 μg/mL) suppressed both cell types, indicating dual regulatory activity. Methanolic fraction further inhibited neutrophilic inflammation and SARS-CoV-2 spike/ACE2 pseudovirus activity. UPLC-MS/MS and GNPS molecular networking identified major compounds in the active methanolic fraction, including gallic acid, ellagic acid, geraniin, corilagin, and vitexin. Additional compounds isolated from the n -hexane fraction included major gallic acid, vitamin α-tocopherol, carotenoid lutein and triterpenes friedelin and epifriedelanol acetate ([ Fig. 1 ]). Structural characterization was confirmed via 1D/2D NMR and mass spectrometry. Key constituents – gallic acid, geraniin, and friedelin – demonstrated dual action by promoting osteoblast formation and/or inhibiting osteoclastogenesis. Fig. 1 Overview of the Bischofia javanica study These findings support the potential of B. javanica as a therapeutic agent for bone-related disorders, particularly osteoporosis. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Raviraj, T., Wei, W., Hung, T., Hsiao, J., Tenderly, V. F., Loo, Y. C., Renadi, S., Delica-Balagot, K., Panjaitan, R. S., Mykhailenko, O., El-Shazly, M., Safratova, M., Chen, Y., Hwang, T., Chang, F., & Korinek, M. (2026). Osteoblast and osteoclast modulation by triterpenes and ellagitannins from Bischofia javanica leaves. Planta Medica, 92(03), 212-213. https://doi.org/10.1055/s-0045-1814898
Vancouver
Raviraj T, Wei W, Hung T, Hsiao J, Tenderly VF, Loo YC, et al. Osteoblast and osteoclast modulation by triterpenes and ellagitannins from Bischofia javanica leaves. Planta Medica. 2026;92(03):212-213. doi:10.1055/s-0045-1814898
BibTeX
@article{Raviraj2026,
author = {Raviraj, T and Wei, W-C and Hung, T-H and Hsiao, J and Tenderly, V F and Loo, Y C and Renadi, S and Delica-Balagot, K and Panjaitan, R S and Mykhailenko, O and El-Shazly, M and Safratova, M and Chen, Y-L and Hwang, T-L and Chang, F-R and Korinek, M},
title = {Osteoblast and osteoclast modulation by triterpenes and ellagitannins from Bischofia javanica leaves},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {212--213},
doi = {10.1055/s-0045-1814898}
}
EUVIMED